3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Breast Neoplasms
52
Carcinoma, Renal Cell
47
Neoplasm Metastasis
24
Neoplasms
18
Kidney Neoplasms
18
Neuroendocrine Tumors
17
Carcinoma, Non-Small-Cell Lung
13
Tuberous Sclerosis
12
Stomach Neoplasms
12
Lymphoma, Mantle-Cell
12
Lymphoma, Large B-Cell, Diffuse
11
Recurrence
10
Prostatic Neoplasms
10
Lymphoma
10
Hodgkin Disease
10
Glioblastoma
10
Colorectal Neoplasms
10
Precursor Cell Lymphoblastic Leukemia-Lymphoma
9
Brain Neoplasms
9
Lymphoma, Follicular
8
Lung Neoplasms
8
Leukemia, Lymphocytic, Chronic, B-Cell
8
Carcinoma
8
Waldenstrom Macroglobulinemia
7
Triple Negative Breast Neoplasms
7
Sarcoma
7
Multiple Myeloma
7
Lymphoma, B-Cell, Marginal Zone
7
Glioma
7
Central Nervous System Neoplasms
7
Interventions
aldesleukin
9
Interleukin-2
9
Nivolumab
7
fludarabine phosphate
6
Dacarbazine
6
Cyclophosphamide
6
fludarabine
5
Temozolomide
4
Ipilimumab
4
Fluorouracil
4
montanide ISA 51
3
Surveys and Questionnaires
3
Semaxinib
3
Radiotherapy
3
Radiation
3
Mohs Surgery
3
Educational Status
3
Cisplatin
3
Allovectin-7
3
zanolimumab
2
talabostat
2
sonidegib
2
poly ICLC
2
binimetinib
2
Whole-Body Irradiation
2
Vinblastine
2
Vemurafenib
2
Tacrolimus
2
Tablets
2
Surgical Procedures, Operative
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Skin Neoplasms
×
Everolimus
×
Clear all
NCT00799188
2025-12-19
CERTICOEUR
Hospices Civils de Lyon
Phase 3
Completed
175 enrolled